CDC42 and cancer: CDC42 has previously been proven to regulate mechanotransduction responses, such as endothelial migration [40,41], osteoblast β-catenin signaling [42], integrin signaling [43], morphology and differentiation of mesenchymal stem cells [44], and stiffness-induced dormancy of cancer cells [30].